Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,249 | 324 | 99.6% |
| Education | $21.40 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,497 | 109 | $0 (2024) |
| PFIZER INC. | $415.36 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $347.88 | 24 | $0 (2024) |
| Lilly USA, LLC | $337.81 | 20 | $0 (2024) |
| ABBVIE INC. | $297.94 | 15 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $293.75 | 10 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $245.43 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $217.15 | 14 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $137.90 | 9 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $124.66 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $956.09 | 52 | Novo Nordisk Inc ($357.75) |
| 2023 | $959.75 | 49 | Novo Nordisk Inc ($297.06) |
| 2022 | $669.68 | 41 | Novo Nordisk Inc ($231.05) |
| 2021 | $640.52 | 45 | Novo Nordisk Inc ($237.11) |
| 2020 | $450.90 | 30 | Novo Nordisk Inc ($132.43) |
| 2019 | $412.16 | 28 | Lilly USA, LLC ($56.22) |
| 2018 | $537.63 | 35 | PFIZER INC. ($137.77) |
| 2017 | $643.41 | 45 | Novo Nordisk Inc ($150.65) |
All Payment Transactions
325 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: UROLOGY | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: PAIN | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Obesity | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Diabetes | ||||||
| 11/02/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: UROLOGY | ||||||
| 10/17/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: UROLOGY | ||||||
| 10/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: VACCINES | ||||||
| 08/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Obesity | ||||||
| 08/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Oncology | ||||||
| 08/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Cardio-renal | ||||||
| 08/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Diabetes | ||||||
| 08/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Diabetes | ||||||
| 07/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Biological | ||||||
| 07/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,032 | 1,099 | $132,995 | $94,104 |
| 2022 | 11 | 1,120 | 1,212 | $138,446 | $98,058 |
| 2021 | 10 | 1,063 | 1,259 | $131,826 | $91,128 |
| 2020 | 12 | 1,175 | 1,371 | $135,396 | $76,844 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 315 | 315 | $42,525 | $36,152 | 85.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 60 | 60 | $21,000 | $16,086 | 76.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 203 | $28,420 | $13,616 | 47.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 169 | 219 | $21,243 | $10,254 | 48.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 102 | 102 | $8,232 | $7,657 | 93.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 23 | 23 | $3,795 | $3,430 | 90.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 110 | 110 | $3,280 | $3,161 | 96.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $2,970 | $2,261 | 76.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 56 | 56 | $1,530 | $1,486 | 97.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 292 | 292 | $39,420 | $35,930 | 91.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 226 | 253 | $35,420 | $16,516 | 46.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 59 | 59 | $20,650 | $16,411 | 79.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 181 | 240 | $23,280 | $11,165 | 48.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 101 | 103 | $7,711 | $7,088 | 91.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 27 | 27 | $4,455 | $4,309 | 96.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 109 | 111 | $2,739 | $2,686 | 98.0% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 15 | 15 | $2,316 | $1,993 | 86.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 77 | 77 | $1,741 | $1,711 | 98.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 11 | 11 | $330.00 | $167.60 | 50.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 22 | 24 | $384.00 | $82.75 | 21.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 267 | 267 | $36,045 | $33,576 | 93.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 245 | 395 | $38,315 | $21,475 | 56.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 247 | 289 | $40,460 | $20,643 | 51.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 106 | 107 | $6,742 | $6,711 | 99.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 20 | 20 | $3,300 | $3,240 | 98.2% |
About Dr. Justin Bailey, MD
Dr. Justin Bailey, MD is a Internal Medicine healthcare provider based in Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992784243.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Justin Bailey, MD has received a total of $5,270 in payments from pharmaceutical and medical device companies, with $956.09 received in 2024. These payments were reported across 325 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($5,249).
As a Medicare-enrolled provider, Bailey has provided services to 4,390 Medicare beneficiaries, totaling 4,941 services with total Medicare billing of $360,134. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Charleston, WV
- Active Since 01/14/2006
- Last Updated 08/07/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1992784243
Products in Payments
- Ozempic (Drug) $860.85
- Rybelsus (Drug) $352.33
- XARELTO (Drug) $275.29
- FARXIGA (Drug) $242.87
- NURTEC ODT (Drug) $186.18
- UBRELVY (Drug) $156.01
- ELIQUIS (Drug) $145.91
- GEMTESA (Drug) $140.93
- XIFAXAN (Drug) $137.90
- TRELEGY ELLIPTA (Drug) $115.66
- TRADJENTA (Drug) $112.66
- Victoza (Drug) $108.69
- TRULICITY (Drug) $108.11
- MOUNJARO (Drug) $98.49
- QULIPTA (Drug) $98.46
- JANUVIA (Drug) $86.77
- CHANTIX (Drug) $83.49
- JARDIANCE (Drug) $82.31
- Trintellix (Drug) $81.00
- Kerendia (Drug) $80.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charleston
William Chapman, Do, DO
Internal Medicine — Payments: $1.3M
Dr. Ryan Tedford, M.d, M.D
Internal Medicine — Payments: $432,170
Harold Szerlip, Md, MD
Internal Medicine — Payments: $284,278
Dr. Nathan Shores, M.d, M.D
Internal Medicine — Payments: $262,570
Hamza Hashmi, M.d, M.D
Internal Medicine — Payments: $234,146
Dr. Anne Kroman, D.o., Phd, D.O., PHD
Internal Medicine — Payments: $202,518